Swiss Life Asset Management Ltd Increases Position in Agilent Technologies, Inc. $A

Swiss Life Asset Management Ltd grew its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 7.7% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 68,703 shares of the medical research company’s stock after buying an additional 4,928 shares during the quarter. Swiss Life Asset Management Ltd’s holdings in Agilent Technologies were worth $8,818,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Groupama Asset Managment grew its position in Agilent Technologies by 109.1% in the 3rd quarter. Groupama Asset Managment now owns 4,756 shares of the medical research company’s stock valued at $610,000 after acquiring an additional 2,482 shares during the last quarter. Investment Research Partners LLC bought a new stake in shares of Agilent Technologies during the third quarter worth $421,000. CIBC Bancorp USA Inc. purchased a new stake in shares of Agilent Technologies during the third quarter valued at $5,030,000. Center For Asset Management LLC bought a new position in shares of Agilent Technologies in the third quarter worth about $234,000. Finally, Captrust Financial Advisors grew its holdings in shares of Agilent Technologies by 2.4% in the third quarter. Captrust Financial Advisors now owns 43,179 shares of the medical research company’s stock worth $5,542,000 after purchasing an additional 1,021 shares during the last quarter. 87.41% of the stock is owned by institutional investors.

Agilent Technologies Stock Down 0.5%

Shares of Agilent Technologies stock opened at $111.18 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. The stock has a market cap of $31.42 billion, a price-to-earnings ratio of 24.54, a PEG ratio of 2.35 and a beta of 1.31. The firm’s 50-day moving average is $126.87 and its two-hundred day moving average is $135.33. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.81 billion. During the same quarter in the prior year, the firm posted $1.31 EPS. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.255 per share. The ex-dividend date is Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. Agilent Technologies’s dividend payout ratio is currently 22.52%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Citigroup lifted their price objective on shares of Agilent Technologies from $165.00 to $185.00 and gave the company a “buy” rating in a report on Tuesday, November 25th. Barclays dropped their target price on shares of Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating on the stock in a research note on Thursday, February 26th. Wells Fargo & Company reduced their target price on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research report on Thursday, February 26th. HSBC initiated coverage on Agilent Technologies in a report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price target for the company. Finally, Robert W. Baird increased their price objective on Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 25th. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $161.20.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.